Evidence map›Paper›PMID 14960606›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2004

In vitro ischemic tolerance involves upregulation of glutamate transport partly mediated by the TACE/ADAM17-tumor necrosis factor-alpha pathway.

Cristina Romera, Olivia Hurtado, Sofia H Botella, Ignacio Lizasoain, Antonio Cárdenas, Paz Fernández-Tomé, Juan C Leza, Pedro Lorenzo, Maria A Moro

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 130 citations in OpenAlex.

  1. Review
  2. Normobaric Hyperoxia Therapy in Treating Stroke.Clinical interventions in aging · 2025
    Review
  3. Spinal Cord Stimulation Increases Chemoefficacy and Prevents Paclitaxel-Induced Pain via CX3CL1.Neuromodulation : journal of the International Neuromodulation Society · 2023
    Article
  4. Tissue-type plasminogen activator induces TNF-α-mediated preconditioning of the blood-brain barrier.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  5. Review
  6. Neuregulin-1 inhibits CoClMolecular brain · 2020
    Article
  7. Article
  8. Review
  9. Neuregulin1 Attenuates HNeurotoxicity research · 2019
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Cristina RomeraDepartamento de Farmacología, Consejo Superior de Investigaciones Científicas, Facultad de Medicina, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Olivia Hurtado
Sofia H Botella
Ignacio Lizasoain
Antonio Cárdenas
Paz Fernández-Tomé
Juan C Leza
Pedro Lorenzo
Maria A Moro
Istituto di Farmacologia Traslazionale · ITUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A short ischemic event [ischemic preconditioning (IPC)] can result in a subsequent resistance to severe ischemic injury (ischemic tolerance). Although tumor necrosis factor-alpha (TNF-alpha) contributes to the brain damage found after cerebral ischemia, its expression and neuroprotective role in models of IPC have also been described. Regarding the role of TNF-alpha convertase (TACE/ADAM17), we have recently shown its upregulation in rat brain after IPC induced by transient middle cerebral artery occlusion and that subsequent TNF-alpha release accounts for at least part of the neuroprotection found in this model. We have now used an in vitro model of IPC using rat cortical cultures exposed to sublethal oxygen-glucose deprivation (OGD) to investigate TACE expression and activity after IPC and the subsequent mechanisms of ischemic tolerance. OGD-induced cell death was significantly reduced in cells exposed to IPC by sublethal OGD 24 hr before, an effect that was inhibited by the TACE inhibitor BB3103 (1 microm) and anti-TNF-alpha antibody (2 microg/ml) and that was mimicked by TNF-alpha (10 pg/ml) preincubation. Western blot analysis showed that TACE expression is increased after IPC. IPC caused TNF-alpha release, an effect that was blocked by the selective TACE inhibitor BB-3103. In addition, IPC diminished the increase in extracellular glutamate caused by OGD and increased cellular glutamate uptake and expression of EAAT2 and EAAT3 glutamate transporters; however, only EAAT3 upregulation was mediated by increased TNF-alpha. These data demonstrate that neuroprotection induced by IPC involves upregulation of glutamate uptake partly mediated by TACE overexpression.

Indexed as

ADAM17 ProteinADAM ProteinsAmino Acid Transport System X-AGAnimalsAntibodiesAstrocytesBiological TransportBrain IschemiaCaspase 3CaspasesCell DeathCells, CulturedCoculture TechniquesEnzyme InhibitorsExcitatory Amino Acid Transporter 2Excitatory Amino Acid Transporter 3ADAM17 ProteinAdam17 protein, ratADAM ProteinsAmino Acid Transport System X-AGAntibodiesBB 3103Casp3 protein, ratCaspase 3CaspasesEnzyme InhibitorsExcitatory Amino Acid Transporter 2Excitatory Amino Acid Transporter 3GlucoseGlutamate Plasma Membrane Transport ProteinsGlutamic AcidHydroxamic AcidsMetalloendopeptidasesSlc1a1 protein, ratSlc1a2 protein, ratSymportersTumor Necrosis Factor-alpha

Identifiers

PMID14960606
PMCPMC6730348
OpenAlexW2051861534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.